كل ما تود معرفته عن BioNTech

U.S. FDA, CDC See Early Signal of Possible Pfizer Bivalent COVID Shot Link to Stroke

A safety monitoring system flagged that U.S. drugmaker Pfizer Inc (PFE.N) and German partner BioNTech's updated COVID-19 shot could be linked to a type of brain stroke in older adults, according to…

15 January 2023

A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier/File Photo

Pfizer/BioNTech Seek FDA Nod For New COVID Boosters For Children

Pfizer Inc (PFE.N) and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through…

26 September 2022

A healthcare worker prepares to administer a Pfizer/BioNTEch coronavirus disease (Covid-19) vaccine at The Michener Institute, in Toronto, Ontario on December 14, 2020. - Ontario, Canada's most populous province and one of the hardest hit by the pandemic, had 1,940 new cases and 23 deaths on Monday. The province is expected to give its next doses to nursing home workers as a priority, according to media reports. (Photo by CARLOS OSORIO / POOL / AFP) (Photo by CARLOS OSORIO/POOL/AFP via Getty Images)

Here’s Why the FDA Shouldn’t Rush Giving Full Approval to the COVID Vaccines

It’s undoubtedly a coincidence, but two commentators I find most thoughtful and trustworthy both weighed in Wednesday on the question of whether the Food and Drug Administration should just go ahead…

Michael Hiltzik 25 July 2021

Popular
Editor's Pick

People shout slogans as they gather after a two-week ceasefire in the Iran war was announced, in Tehran, Iran, 8 April 2026.

Majid Asgaripour / Reuters

Politics

US-Iran ceasefire unlikely to hold

07 April 2026

If the ceasefire collapses, China has an interest in getting the two sides back to the table, but it would be a difficult task given Tehran's deep mistrust of the US and Israel.

Xiaotong Yang

Al Majalla

Politics

5 unanswered questions on the US-Iran ceasefire

09 April 2026

The fragile truce faces significant obstacles.

John Haltiwanger

Al Majalla

Politics

The US-Iran war tanked Trump's popularity at home

07 April 2026

Instead of the "no endless wars" they were promised, Americans were thrown into a disastrous war and were feeling the economic pinch at the gas pump

Brian Katulis

Awami Rickshaw Union workers holding posters of Pakistan's Chief of Army Staff, Field Marshal Asim Munir, shout slogans after the US and Iran agreed to a two-week ceasefire in Lahore on 8 April 2026.

Arif ALI / AFP

Politics

Behind the truce: Pakistan mediation proves pivotal

08 April 2026

Islamabad is humming with behind-the-scenes diplomacy to turn this tentative pause into lasting peace.

Kaswar Klasra

Israeli Prime Minister Benjamin Netanyahu and Israeli National Security Minister Itamar Ben-Gvir shake hands during a session at the Knesset in Jerusalem, on 29 March 2026.

Reuters

Politics

Palestinian executions are now official Israel policy

08 April 2026

Israel's parliament approved a draconian death penalty law last week that only applies to Palestinian prisoners, in a move that the UN says "would constitute a war crime"

Khaled Essam Eleslamboly

Sections

Regions

More

LATEST ISSUE

BioNTech

U.S. FDA, CDC See Early Signal of Possible Pfizer Bivalent COVID Shot Link to Stroke

Pfizer/BioNTech Seek FDA Nod For New COVID Boosters For Children

Here’s Why the FDA Shouldn’t Rush Giving Full Approval to the COVID Vaccines

US-Iran ceasefire unlikely to hold

5 unanswered questions on the US-Iran ceasefire

The US-Iran war tanked Trump's popularity at home

Behind the truce: Pakistan mediation proves pivotal

Palestinian executions are now official Israel policy

OPINIONS

Three leaders rule Iran

Iran's out-of-sight Supreme Leader fuels speculation

Israel's Lebanon attacks threaten fragile US-Iran truce

Behind the truce: Pakistan mediation proves pivotal

BioNTech

Sign up for the Weekly Newsletter